Capreomycin

Capastat 1 G Polvo Para Solucion Inyectable.

1 g polvo para solución inyectableSpainWithdrawnAuthorised 31 May 1968

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Capastat PWS IM 1G VialCanada · 1 G / VIAL · Powder For Solution · Eli Lilly Canada INCSame brand
Capastat SulfateUnited States · 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · Epic Pharma LLCSame brand
Capreomycin SulfateUnited States · 1GM BASE/VIAL · injectable · Hisun Pharm HangzhouSame form

Packs

Pack	Code	Status
CAPASTAT 1 G POLVO PARA SOLUCION INYECTABLE. , 1 vial	687202

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Capreomycin

Capastat 1 G Polvo Para Solucion Inyectable.

1 g polvo para solución inyectableSpainWithdrawnAuthorised 31 May 1968

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
CAPASTAT 1 G POLVO PARA SOLUCION INYECTABLE. , 1 vial	687202

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Summary of product characteristicsAEMPS

Package leafletAEMPS

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Capreomycin
Strength: 1 g
Dosage form: polvo para solución inyectable
Route: vía intramuscular
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 31 May 1968
Registration: 45261
Marketing authorisation holder: Vianex S.A.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración